Skip to main content

COVID-19 Medicines

COVID-19 treatments may be available for eligible patients at increased risk of severe illness. This page provides information on patient eligibility, referral pathways and treatment options in line with current guidance.

The prescribing guidance, formularies, pathways and information on this website have transferred from the predecessor organisations that now form NHS Central East ICB.

Guidance may not be available for all clinical topics or geographic areas. Where guidance is available, it is clearly identified as applying to Bedfordshire, Luton and Milton Keynes (BLMK), Cambridgeshire and Peterborough (C&P), Hertfordshire or Central East (CE).

Guidance labelled Central East (CE) has been harmonised and approved for use across NHS Central East ICB. Where CE guidance is not available, local arrangements for BLMK, C&P or Hertfordshire remain in place.

Bedfordshire, Luton and Milton Keynes

COVID Medicines Delivery Unit (CMDU) – Referral Criteria (docx)

COVID Medicines Delivery Unit (CMDU) – Referral Form Process (Bedfordshire) (pdf)

COVID Medicines Delivery Unit (CMDU) – Referral Form Process (Luton) (pdf)

COVID Medicines Delivery Unit (CMDU) – Referral Form Process (Milton Keynes) (pdf)

COVID Medicines Delivery Unit (CMDU) – Referral Proforma (docx)

Cambridgeshire and Peterborough

Paxlovid (Nirmatrelvir and Ritonavir) for Eligible Non-Hospitalised patients (18 years and over) with COVID-19 – Prescribing Support Document (pdf)

COVID-19 treatment prescribing and referral template: Support Document (pdf)

Hertfordshire

COVID-19 treatments: Information for community pharmacists (pdf)

Community LRTI Pneumonia Intravenous Antibiotic pathway for Housebound Care Home patients Pathway (pdf)

COVID-19 treatments: Information for clinicians (pdf)